Moreover, it has been demonstrated that the knockdown of RXRα decreased the survival of CCA cells by reducing the expression of two G1/S regulators, such as cyclin D1 and E, leading to cell-cycle arrest [105]. The gene discussed is RXRA; the disease is cholangiocarcinoma.